ABCL
Price
$3.80
Change
+$0.05 (+1.33%)
Updated
Jul 3 closing price
Capitalization
1.13B
36 days until earnings call
IPA
Price
$1.31
Change
+$0.25 (+23.58%)
Updated
Jul 3 closing price
Capitalization
59.95M
Interact to see
Advertisement

ABCL vs IPA

Header iconABCL vs IPA Comparison
Open Charts ABCL vs IPABanner chart's image
AbCellera Biologics
Price$3.80
Change+$0.05 (+1.33%)
Volume$1.95M
Capitalization1.13B
ImmunoPrecise Antibodies
Price$1.31
Change+$0.25 (+23.58%)
Volume$2.71M
Capitalization59.95M
ABCL vs IPA Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. IPA commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and IPA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ABCL: $3.80 vs. IPA: $1.31)
Brand notoriety: ABCL and IPA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 34% vs. IPA: 114%
Market capitalization -- ABCL: $1.13B vs. IPA: $59.95M
ABCL [@Biotechnology] is valued at $1.13B. IPA’s [@Biotechnology] market capitalization is $59.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileIPA’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • IPA’s FA Score: 0 green, 5 red.
According to our system of comparison, IPA is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while IPA’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 4 bearish.
  • IPA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than IPA.

Price Growth

ABCL (@Biotechnology) experienced а +1.60% price change this week, while IPA (@Biotechnology) price change was +18.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.13B) has a higher market cap than IPA($60M). IPA YTD gains are higher at: 218.193 vs. ABCL (29.693). IPA has higher annual earnings (EBITDA): -45.11M vs. ABCL (-211.2M). ABCL has more cash in the bank: 605M vs. IPA (12.9M). IPA has less debt than ABCL: IPA (12.9M) vs ABCL (67.8M). IPA (24M) and ABCL (23.1M) have equivalent revenues.
ABCLIPAABCL / IPA
Capitalization1.13B60M1,890%
EBITDA-211.2M-45.11M468%
Gain YTD29.693218.19314%
P/E RatioN/AN/A-
Revenue23.1M24M96%
Total Cash605M12.9M4,690%
Total Debt67.8M12.9M526%
FUNDAMENTALS RATINGS
IPA: Fundamental Ratings
IPA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLIPA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 5 days ago
74%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 26 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWZLX20.370.19
+0.94%
Nationwide Loomis All Cap Gr A
DSCIX14.190.11
+0.78%
Dana Epiphany Small Cap Eq Instl
OILVX20.020.13
+0.65%
Optimum Large Cap Value Instl
OTIIX57.360.36
+0.63%
T. Rowe Price Small-Cap Stock I
MDLVX31.230.19
+0.61%
BlackRock Advantage Large Cap Val Inv A

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+1.33%
CRSP - ABCL
62%
Loosely correlated
+0.97%
RXRX - ABCL
61%
Loosely correlated
+1.15%
ABSI - ABCL
57%
Loosely correlated
+2.97%
BEAM - ABCL
57%
Loosely correlated
+0.65%
NTLA - ABCL
57%
Loosely correlated
+0.09%
More

IPA and

Correlation & Price change

A.I.dvisor tells us that IPA and TPST have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPA and TPST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPA
1D Price
Change %
IPA100%
+23.58%
TPST - IPA
28%
Poorly correlated
N/A
ITRM - IPA
23%
Poorly correlated
-0.42%
LTRN - IPA
23%
Poorly correlated
+2.20%
GANX - IPA
23%
Poorly correlated
+3.36%
ABCL - IPA
22%
Poorly correlated
+1.33%
More